The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Chimeric Nucleases Stimulate Gene Targeting in Human Cells
Abstract
Correction of gene defects in human somatic cells by targeting as has been used in murine embryonic stem cells (1, 2) has been precluded by the low spontaneous rate of gene targeting (3). However, creation of a DNA double-stranded break (DSB) in the genomic target (DSB-GT) can stimulate homologous recombination by over 1000-fold (4). \n \nWe can rapidly and quantitatively measure gene targeting by correcting a mutation in a green fluorescent protein (GFP) gene that has been stably integrated into the genome (5) (fig. S1). With an optimized GFP gene targeting system, the introduction of a DSB by I–Sce I (Sce) stimulated GT >40,000-fold and the absolute rate of gene targeting reached 3 to 5% (fig. S2). Such a system, however, depends on the prior introduction of a Sce binding site into the target gene and cannot be used for endogenous genes. Chimeric nucleases (CNs) have the potential to create sequence-specific DSBs (6). CNs—fusions between zinc finger binding DNA binding domains and the endonuclease domain of Fok I—can sitespecifically cleave naked DNA in vitro (6), extrachromosomal DNA in Xenopus oocytes (7), and chromosomal DNA in Drosophila (8). CNs work as dimers, and their efficiency depends on the spacing and orientation of the zinc finger binding sites with respect to the length of the amino acid linker between the DNA binding and endonuclease domains (7, 9). \n \nQQR is an artificial zinc finger DNA binding domain that recognizes the sequence 5′-GGGGAAGAA-3′ with nanomolar affinity (10). We modified QQR chimeric nucleases (QQR-CNs) (7, 9) (Fig. 1A) and tested whether they stimulated gene targeting (Fig. 1B). The background rate of gene targeting was 0.71 events per million transfected cells (fig. S1C). QQRL18-CN stimulated gene targeting 17-fold on target QQR6 and 260-fold on target QQR8 (Fig. 1B). QQRL0-CN did not stimulate gene targeting on target QQR8, but it was as efficient as Sce in stimulating gene targeting by over 2000-fold on target QQR6 (Fig. 1B). QQRL18-CN showed some preference for an 8–base pair (bp) spacing between binding sites whereas QQRL0-CN preferred 6-bp spacing. Thus, removing the linker between the zinc spacfinger and the nuclease domains increased the activity and specificity of the fusion protein in mammalian cells. As controls, we showed that the CNs did not stimulate gene targeting if (i) they lacked a nuclear localization signal, (ii) there was a single binding site rather than an inverted repeat binding site in the target, and (iii) the cognate binding site was changed. Thus, homodimers of CNs are potent stimulators of gene targeting in human somatic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, if the nuclease action mutates unintended targets that are important for cellular physiology, the treated cells may become dysfunctional or even die [61,62,63].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [62]
In the citing paper
“The fundamental safety concern for using ZFN mediated gene disruption for human therapy is the specificity of gene targeting.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [62]
Citations
Cites
Altering the Genome by Homologous Recombination
Capecchi, M. R. (1989) · Science · doi:10.1126/science.2660260 · Cited by 2,037
DNA Recognition by Cys2His2 Zinc Finger Proteins
Wolfe, S. A., Nekludova, L., & Pabo, C. O. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.183 · Cited by 1,053
Targeted Chromosomal Cleavage and Mutagenesis in Drosophila Using Zinc-Finger Nucleases
Bibikova, M., Golic, M., Golic, K. G., & Carroll, D. (2002) · Genetics · doi:10.1093/genetics/161.3.1169 · Cited by 860
Targetted correction of a mutant HPRT gene in mouse embryonic stem cells
Doetschman, T., Gregg, R., Maeda, N., Hooper, M., Melton, D., Thompson, S., & Smithies, O. (1987) · Nature · doi:10.1038/330576a0 · Cited by 756
Stimulation of Homologous Recombination through Targeted Cleavage by Chimeric Nucleases
Bibikova, M. V., Carroll, D., Segal, D. J., Trautman, J. K., Smith, J., Kim, Y., & Chandrasegaran, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.289-297.2001 · Cited by 614
Smith, J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.17.3361 · Cited by 425
Genetic manipulation of genomes with rare-cutting endonucleases
Jasin, M. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)10019-6 · Cited by 391
Positive genetic selection for gene disruption in mammalian cells by homologous recombination.
Sedivy, J. M., & Sharp, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.227 · Cited by 119
Specific DNA-RNA Hybrid Binding by Zinc Finger Proteins
Shi, Y., & Berg, J. M. (1995) · Science · doi:10.1126/science.7536342 · Cited by 86
Chimeric Restriction Enzymes: What Is Next?
Chandrasegaran, S., & Smith, J. (1999) · Biological Chemistry · doi:10.1515/bc.1999.103 · Cited by 85
Flagged first, then by citations
Research works printed but not linked: 1
- S. Chandrasegaran, J. Smith, Biol. Chem.380, 841 (1999).
Cited by
Sorted by citations
Items 201–300 of 740
CRISPR-Cas9 technology: applications and human disease modelling
Torres-Ruiz, R., & Rodríguez, S. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw025 · Cited by 77
Towards therapeutic applications of engineered zinc finger proteins
Klug, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.104 · Cited by 74
Daboussi, F., Zaslavskiy, M., Poirot, L., Loperfido, M., Gouble, A., Guyot, V., Leduc, S., Galetto, R., Grizot, S., Oficjalska, D., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks268 · Cited by 80
Targeted mutagenesis using zinc-finger nucleases in perennial fruit trees
Peer, R., Rivlin, G., Golobovich, S., Lapidot, M., Gal‐On, A., Vainstein, A., Tzfira, T., & Flaishman, M. A. (2014) · Planta · doi:10.1007/s00425-014-2224-x · Cited by 73
May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells
Brookhouser, N., Raman, S., Potts, C., & Brafman, D. A. (2017) · Cells · doi:10.3390/cells6010005 · Cited by 75
Genome engineering: a new approach to gene therapy for neuromuscular disorders
Nelson, C. E., Robinson-Hamm, J. N., & Gersbach, C. A. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.126 · Cited by 73
Towards a new era in medicine: therapeutic genome editing
Porteus, M. H. (2015) · Genome Biology · doi:10.1186/s13059-015-0859-y · Cited by 69
Self-citationImmunological barriers to haematopoietic stem cell gene therapy
Charlesworth, C. T., Hsu, I., Wilkinson, A. C., & Nakauchi, H. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00698-0 · Cited by 71
Jaskula-Ranga, V., Wahlin, K. J., Maruotti, J., & Zack, D. J. (2014) · Nature Communications · doi:10.1038/ncomms5516 · Cited by 74
Thalassemia: An Overview of 50 Years of Clinical Research
Sankaran, V. G., & Nathan, D. G. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.009 · Cited by 68
Genome modifications in plant cells by custom‐made restriction enzymes
Tzfira, T., Weinthal, D., Marton, I., Zeevi, V., Zuker, A., & Vainstein, A. (2012) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2011.00672.x · Cited by 70
Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
Allen, A. G., Chung, C.-H., Atkins, A., Dampier, W., Khalili, K., Nonnemacher, M. R., & Wigdahl, B. L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02940 · Cited by 70
Artificial Restriction DNA Cutters as New Tools for Gene Manipulation
Katada, H., & Komiyama, M. (2009) · ChemBioChem · doi:10.1002/cbic.200900040 · Cited by 68
New Redesigned Zinc‐Finger Proteins: Design Strategy and Its Application
Negi, S., Imanishi, M., Matsumoto, M., & Sugiura, Y. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200701320 · Cited by 68
Stem Cell Models of Cardiac Development and Disease
Musunuru, K., Domian, I. J., & Chien, K. R. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-103948 · Cited by 71
A morphospace for synthetic organs and organoids: the possible and the actual
Ollé-Vila, A., Duran‐Nebreda, S., Pueyo, N. C., Montañez, R., & Solé, R. V. (2016) · Integrative Biology · doi:10.1039/c5ib00324e · Cited by 66
Forsyth, A., Weeks, T., Richael, C. M., & Duan, H. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01572 · Cited by 68
Transcription activator like effector (TALE)-directed piggyBac transposition in human cells
Owens, J. B., Mauro, D., Stoytchev, I., Bhakta, M. S., Kim, M., Segal, D. J., & Moisyadi, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt677 · Cited by 69
Duranthon, V., Beaujean, N., Brunner, M. P., Odening, K. E., Santos, A. N., Kacskovıcs, I., Hiripi, L., Weinstein, E. J., & Bösze, Z. (2012) · Transgenic Research · doi:10.1007/s11248-012-9599-x · Cited by 67
New developments in the use of gene therapy to treat Duchenne muscular dystrophy
Jarmin, S., Kymäläinen, H., Popplewell, L. J., & Dickson, G. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.866087 · Cited by 69
Wu, K., Shirk, P. D., Taylor, C., Furlong, R. B., Shirk, B. D., Pinheiro, D. H., & Siegfried, B. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208647 · Cited by 65
Recent advances and challenges of biosensing in point-of-care molecular diagnosis
Chu, H., Liu, C., Liu, J., Yang, J., Li, Y., & Zhang, X. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130708 · Cited by 68
Designed nucleases for targeted genome editing
Lee, J., Chung, J., Kim, H. M., Kim, S., & Kim, S. (2015) · Plant Biotechnology Journal · doi:10.1111/pbi.12465 · Cited by 70
Deconstructing Pancreas Development to Reconstruct Human Islets from Pluripotent Stem Cells
McKnight, K. D., Wang, P., & Kim, S. K. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.003 · Cited by 62
Mashimo, T. (2013) · Development Growth & Differentiation · doi:10.1111/dgd.12110 · Cited by 70
RNA-guided retargeting of Sleeping Beauty transposition in human cells
Kovač, A., Miskey, C., Menzel, M., Grueso, E., Gogol‐Döring, A., & Ivics, Z. (2020) · eLife · doi:10.7554/elife.53868 · Cited by 61
Gommans, W. M., Haisma, H. J., & Rots, M. G. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.082 · Cited by 66
Dever, D. P., & Porteus, M. H. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000385 · Cited by 62
Self-citationGene therapy for primary immunodeficiency
Booth, C., Romano, R., Roncarolo, M. G., & Thrasher, A. J. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz170 · Cited by 63
RNA-driven genetic changes in bacteria and in human cells
Shen, Y., Nandi, P., Taylor, M. B., Stuckey, S., Bhadsavle, H. P., Weiss, B., & Storici, F. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.03.016 · Cited by 62
Gene editing: not just for translation anymore
McMahon, M. A., Rahdar, M., & Porteus, M. H. (2011) · Nature Methods · doi:10.1038/nmeth.1811 · Cited by 64
Self-citationCustomizing the genome as therapy for the β-hemoglobinopathies.
Canver, M. C., & Orkin, S. H. (2016) · Blood · doi:10.1182/blood-2016-01-678128 · Cited by 61
Improved Cell-Penetrating Zinc-Finger Nuclease Proteins for Precision Genome Engineering
Liu, J., Gaj, T., Wallen, M. C., & Barbas, C. F. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.6 · Cited by 61
Endonucleases: new tools to edit the mouse genome
Wijshake, T., Baker, D. J., & van de Sluis, B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.020 · Cited by 61
Chimeric piggyBac transposases for genomic targeting in human cells
Owens, J. B., Urschitz, J., Stoytchev, I., Dang, N. C., Stoytcheva, Z., Belcaid, M., Maragathavally, K. J., Coates, C. J., Segal, D. J., & Moisyadi, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks309 · Cited by 63
A simple and cost-effective method for screening of CRISPR/Cas9-induced homozygous/biallelic mutants
Guo, J., Li, K., Jin, L., Xu, R., Miao, K., Yang, F., Chaoya, Q., Zhang, L., Botella, J. R., Wang, R., et al. (2018) · Plant Methods · doi:10.1186/s13007-018-0305-8 · Cited by 60
Parthiban, K., Perera, R. L., Sattar, M., Huang, Y., Mayle, S., Masters, E. W., Griffiths, D. T., Surade, S. B., Leah, R. A., Dyson, M. R., et al. (2019) · mAbs · doi:10.1080/19420862.2019.1618673 · Cited by 60
Gimble, F. S., Moure, C. M., & Posey, K. L. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.013 · Cited by 60
Ohbayashi, F., Balamotis, M. A., Kishimoto, A., Aizawa, E., Diaz, A., Hasty, P., Graham, F. L., Caskey, C. T., & Mitani, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506598102 · Cited by 61
Collin, J., & Lako, M. (2011) · Stem Cells · doi:10.1002/stem.658 · Cited by 59
Stem Cell-Specific Mechanisms Ensure Genomic Fidelity within HSCs and upon Aging of HSCs
Moehrle, B., Nattamai, K., Brown, A., Florian, M. C., Ryan, M. A., Vogel, M., Bliederhaeuser, C., Soller, K., Prows, D. R., Abdollahi, A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.030 · Cited by 63
Self-citationSuper-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications
Amini, L., Greig, J., Schmueck‐Henneresse, M., Volk, H., Bézie, S., Reinke, P., Guillonneau, C., Wagner, D. L., & Anegón, I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.611638 · Cited by 58
Automated Cell Culture Systems and Their Applications to Human Pluripotent Stem Cell Studies
Daniszewski, M., Crombie, D. E., Henderson, R., Liang, H. H., Wong, R. C. B., Hewitt, A. W., & Pébay, A. (2017) · SLAS TECHNOLOGY · doi:10.1177/2472630317712220 · Cited by 58
The Role of Recombinant AAV in Precise Genome Editing
Bijlani, S., Pang, K. M., Sivanandam, V., Singh, A., & Chatterjee, S. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.799722 · Cited by 63
The application of genome editing in studying hearing loss
Zou, B., Mittal, R., Grati, M., Lu, Z., Shu, Y., Tao, Y., Feng, Y., Xie, D., Kong, W., Yang, S., et al. (2015) · Hearing Research · doi:10.1016/j.heares.2015.04.016 · Cited by 57
Gene Therapy for Skin DiseasesPreprint
Gorell, E. S., Nguyen, N. T., Lane, A. T., & Siprashvili, Z. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015149 · Cited by 56
Modeling disease mutations by gene targeting in one-cell mouse embryos
Meyer, M., Ortiz, O., de Angelis, M. H., Wurst, W., & Kühn, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121203109 · Cited by 55
Asymmetric parental genome engineering by Cas9 during mouse meiotic exit
Suzuki, T., Asami, M., & Perry, A. C. F. (2014) · Scientific Reports · doi:10.1038/srep07621 · Cited by 55
Development of gene therapy for blood disorders: an update
Nienhuis, A. W. (2013) · Blood · doi:10.1182/blood-2013-04-453209 · Cited by 55
Genome editing for inborn errors of metabolism: advancing towards the clinic
Schneller, J. L., Lee, C. M., Bao, G., & Venditti, C. P. (2017) · BMC Medicine · doi:10.1186/s12916-017-0798-4 · Cited by 57
Precision gene editing technology and applications in nephrology
WareJoncas, Z., Campbell, J. M., Martínez‐Gálvez, G., Gendron, W. A. C., Barry, M. A., Harris, P. C., Sussman, C. R., & Ekker, S. C. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0047-x · Cited by 61
Efficient Homology-Directed Repair with Circular Single-Stranded DNA Donors
Iyer, S., Mir, A., Vega‐Badillo, J., Roscoe, B. P., Ibraheim, R., Zhu, L. J., Lee, J., Liu, P., Luk, K., Mintzer, E., et al. (2022) · The CRISPR Journal · doi:10.1089/crispr.2022.0058 · Cited by 63
RNA-Guided Genome Editing of Mammalian Cells
Pyzocha, N., Ran, F. A., Hsu, P. D., & Zhang, F. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-761-7_17 · Cited by 54
Frequent Endonuclease Cleavage at Off-target Locations In Vivo
Petek, L. M., Russell, D. W., & Miller, D. G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.35 · Cited by 54
Metabolic engineering generates a transgene-free safety switch for cell therapy
Wiebking, V., Patterson, J. O., Martin, R. M., Chanda, M. K., Lee, C. M., Srifa, W., Bao, G., & Porteus, M. H. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0580-6 · Cited by 53
Self-citationHistory of genome editing: From meganucleases to CRISPR
Tröder, S. E., & Zevnik, B. (2021) · Laboratory Animals · doi:10.1177/0023677221994613 · Cited by 55
Zinc Finger Nucleases as tools to understand and treat human diseases
Davis, D., & Stokoe, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-42 · Cited by 51
Radecke, F., Peter, I., Radecke, S., Gellhaus, K., Schwarz, K., & Cathomen, T. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.06.008 · Cited by 56
Makino, S., Fukumura, R., & Gondo, Y. (2016) · Scientific Reports · doi:10.1038/srep39608 · Cited by 51
Engineering altered protein–DNA recognition specificity
Bogdanove, A. J., Bohm, A., Miller, J. C., Morgan, R., & Stoddard, B. L. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky289 · Cited by 53
Gene Targeting in Human Pluripotent CellsPreprint
Hockemeyer, D. F., & Jaenisch, R. (2010) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2010.75.021 · Cited by 51
The Mechanism of Gene Targeting in Human Somatic Cells
Kan, Y., Ruis, B. L., Lin, S. G., & Hendrickson, E. A. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004251 · Cited by 50
Sumiyoshi, T., Holt, N. G., Hollis, R. P., Ge, S., Cannon, P. M., Crooks, G. M., & Kohn, D. B. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.109 · Cited by 51
Fajardo-Sánchez, E., Stricher, F., Pâques, F., Isalan, M., & Serrano, L. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn059 · Cited by 50
ZFN-Site searches genomes for zinc finger nuclease target sites and off-target sites
Cradick, T. J., Ambrosini, G., Iseli, C., Bücher, P., & McCaffrey, A. P. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-152 · Cited by 51
Cytosolic Iron-Sulfur Assembly Is Evolutionarily Tuned by a Cancer-Amplified Ubiquitin Ligase
Weon, J. L., Yang, S. W., & Potts, P. R. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.11.010 · Cited by 49
Participation of the Melanocortin-1 Receptor in the UV Control of Pigmentation
Suzuki, I., Im, S., Tada, A., Barsh, G. S., Hearing, V., Scott, C., Akçalı, K. C., Davis, M. B., & ABDEL‐MALEK, Z. A. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640177 · Cited by 49
Connelly, J. P., Barker, J. C., Pruett‐Miller, S. M., & Porteus, M. H. (2010) · Molecular Therapy · doi:10.1038/mt.2010.57 · Cited by 49
Self-citationGene Targeting in Drosophila and Caenorhabditis elegans With Zinc-Finger Nucleases
Carroll, D., Beumer, K. J., Morton, J. J., Bozas, A., & Trautman, J. K. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-232-8_5 · Cited by 48
Efficient in toto targeted recombination in mouse liver by meganuclease‐induced double‐strand break
Gouble, A., Smith, J. N. P., Bruneau, S., Perez, C., Guyot, V., Cabaniols, J., Leduc, S., Fiette, L., Avé, P., Micheau, B., et al. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.879 · Cited by 47
Aluru, N., Karchner, S. I., Franks, D. G., Nacci, D. E., Champlin, D. M., & Hahn, M. E. (2014) · Aquatic Toxicology · doi:10.1016/j.aquatox.2014.11.016 · Cited by 47
Wu, Y. C., Gao, T., Wang, X., Hu, Y., Hu, X., Hu, Z., Pang, J., Li, Z., Xue, J., Feng, M., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.099 · Cited by 47
Gene correction in patient-specific iPSCs for therapy development and disease modeling
Jang, Y.-Y., & Ye, Z. (2016) · Human Genetics · doi:10.1007/s00439-016-1691-5 · Cited by 48
Kolb, A. F., Coates, C. J., Kaminski, J., Summers, J. B., Miller, A. D., & Segal, D. J. (2005) · Trends in biotechnology · doi:10.1016/j.tibtech.2005.06.005 · Cited by 47
Somatic cell nuclear transfer in zebrafish
Siripattarapravat, K., Pinmee, B., Venta, P. J., Chang, C., & Cibelli, J. B. (2009) · Nature Methods · doi:10.1038/nmeth.1369 · Cited by 46
New frontiers in the therapy of primary immunodeficiency: From gene addition to gene editing
Kohn, D. B., & Kuo, C. Y. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.007 · Cited by 48
Overlack, N., Goldmann, T., Wolfrum, U., & Nagel‐Wolfrum, K. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9812 · Cited by 46
Ramalingam, S., London, V., Kandavelou, K., Cebotaru, L., Guggino, W. B., Civin, C. I., & Chandrasegaran, S. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0245 · Cited by 47
Genome editing in zebrafish: a practical overview
Sertori, R., Trengove, M. C., Basheer, F., Ward, A. C., & Liongue, C. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv051 · Cited by 44
Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech
Saha, S. K., Saikot, F. K., Rahman, M. S., Jamal, M. A. H. M., Rahman, S. M. K., Islam, S. M. R., & Kim, K. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.11.016 · Cited by 48
Potentiation of gene targeting in human cells by expression of Saccharomyces cerevisiae Rad52
Primio, C. D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki778 · Cited by 45
Igoucheva, O., Alexeev, V. Y., & Yoon, K. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302643 · Cited by 48
Concise Review: Human Cell Engineering: Cellular Reprogramming and Genome Editing
Mali, P., & Cheng, L. (2011) · Stem Cells · doi:10.1002/stem.735 · Cited by 45
Microinjection and Micromanipulation: A Historical Perspective
Xu, W. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8831-0_1 · Cited by 44
Targeted gene therapies: tools, applications, optimization
Humbert, O., Davis, L., & Maizels, N. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.658112 · Cited by 45
Making ends meet: targeted integration of DNA fragments by genome editing
Yamamoto, Y., & Gerbi, S. A. (2018) · Chromosoma · doi:10.1007/s00412-018-0677-6 · Cited by 49
An overview of development in gene therapeutics in China
Wang, D., Wang, K., & Cai, Y. (2020) · Gene Therapy · doi:10.1038/s41434-020-0163-7 · Cited by 45
Lei, Y., Lee, C.-L., Joo, K.-I., Zarzar, J., Liu, Y., Dai, B., Fox, V., & Wang, P. (2011) · Molecular Therapy · doi:10.1038/mt.2011.12 · Cited by 42
Generation of monoclonal antibody-producing mammalian cell lines
Ho, S. C., Tong, Y. W., & Yang, Y. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.8 · Cited by 41
Hirsch, M. L., Green, L., Porteus, M. H., & Samulski, R. J. (2010) · Gene Therapy · doi:10.1038/gt.2010.65 · Cited by 45
Self-citationEfficient gene targeting mediated by a lentiviral vector-associated meganuclease
Izmiryan, A., Basmaciogullari, S., Henry, A., Pâques, F., & Danos, O. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr524 · Cited by 46
Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9
Oh, H. S., Neuhausser, W., Eggan, P., Angelova, M., Kirchner, R. D., Eggan, K. C., & Knipe, D. M. (2019) · eLife · doi:10.7554/elife.51662 · Cited by 42
Zhang, W., Chen, Y., Yang, J., Zhang, J., Yu, J., Wang, M., Zhao, X., Wei, K., Wan, X., Xu, X., et al. (2020) · eLife · doi:10.7554/elife.56008 · Cited by 42
Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases
Ishida, K., Gee, P., & Hotta, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161024751 · Cited by 41
Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
Huang, Z., Tomitaka, A., Raymond, A., & Nair, M. (2017) · Gene Therapy · doi:10.1038/gt.2017.35 · Cited by 43
Site‐Specific DNA Recombinases as Instruments for Genomic Surgery
Akopian, A., & Stark, W. M. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)55001-6 · Cited by 41
Using Nucleases to Stimulate Homologous Recombination
Carroll, D. (2004) · Humana Press eBooks · doi:10.1385/1-59259-761-0:195 · Cited by 41
CRISPR to fix bad blood: a new tool in basic and clinical hematology
González-Romero, E., Martínez-Valiente, C., García-Ruiz, C., Vázquez‐Manrique, R. P., Cervera, J., & Sanjuán-Pla, A. (2019) · Haematologica · doi:10.3324/haematol.2018.211359 · Cited by 42
Zinc-finger nucleases: new strategies to target the rat genome
Geurts, A. M., & Moreno, C. (2010) · Clinical Science · doi:10.1042/cs20100201 · Cited by 41
Probing the DNA-Binding Affinity and Specificity of Designed Zinc Finger Proteins
Jantz, D., & Berg, J. M. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.11.021 · Cited by 40
Metadata
- Authors
- Porteus, M. H., & Baltimore, D.
- Affiliations
- California Institute of Technology (US)
- Corresponding author
- Porteus, Matthew H.
- Baltimore, David
- Venue
- Science
- Published
- 2003-05-02
- Volume
- 300
- Issue
- 5620
- Pages
- 763-763
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2051395442
- Cited by
- 741
- References
- 10
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 25 · 2023: 16 · 2022: 26 · 2021: 30 · 2020: 34 · 2019: 33 · 2018: 27 · 2017: 28 · 2016: 52 · 2015: 45 · 2014: 69 · 2013: 41 · 2012: 51
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM039458, R01 GM39458)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- gene targeting, homologous recombination, zinc finger DNA-binding domain, DNA double-strand breaks, linker length, somatic cell therapy, gene therapy vectors, somatic cell hybrids, somatic cell nuclear transfer
- MeSH terms
- Cell Line, DNA, Humans, Luminescent Proteins, Mutation, Recombinant Fusion Proteins, Recombination, Genetic, Transfection, Deoxyribonucleases, Type II Site-Specific, Zinc Fingers, Gene Targeting, Dimerization, Nuclear Localization Signals, Saccharomyces cerevisiae Proteins, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
